Providing Comments on CDER Level 2 Guidances | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

Open for Comments

FDA-2017-D-6821

Providing Comments on CDER Level 2 Guidances

Documents

Comments

Key Dates

Comment Period OpensDec 12, 2017

Type	Title	Posted	Comments	Status
Other	Assessing the Effects of Food on Drugs in INDs and NDAs - Clinical Pharmacology Considerations; Guidance for Industry	May 19, 2026	--

Total Comments

guidance